Tech Company Financing Transactions
Aperiam Bio Funding Round
On 11/29/2023, Aperiam Bio announced $9 million in Seed funding from OMX Ventures, Axial VC and Civilization Ventures.
Transaction Overview
Company Name
Announced On
11/29/2023
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand R&D for its wholly owned products and advance its work to-date building partnerships with companies that are tackling the wide array of problems where pulmonary products are the solution.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
99 Washington Avenue Suite 805A
Albany, 12210
USA
Albany, 12210
USA
Phone
Undisclosed
Website
Email Address
Overview
Developer of industrial and therapeutic proteins intended to help create and share stabilized, solubilized, and catalytically optimized proteins. The company's proteins are made using deep learning optimization and an algorithm that illuminates critical parts of protein chemistry to identify novel gain-of-function mutations to engineer biological molecules for agricultural and pharmaceutical applications, enabling researchers to improve lives with hyper-folded proteins and to develop proteins that make them more effective and durable than they are in nature.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Austin Cole
Browse more venture capital transactions:
Prev: 11/29/2023: Soplaya venture capital transaction
Next: 11/29/2023: iPeakoin venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs